相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Harmine induces apoptosis and inhibits tumor cell proliferation, migration and invasion through down-regulation of cyclooxygenase-2 expression in gastric cancer
Hao Zhang et al.
PHYTOMEDICINE (2014)
Sigma 1 Receptor plays a prominent role in IL-24-induced cancer-specific apoptosis
Winchie Do et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Predicting Response to Bevacizumab in Ovarian Cancer: A Panel of Potential Biomarkers Informing Treatment Selection
Fiona Collinson et al.
CLINICAL CANCER RESEARCH (2013)
Developing New Drug Treatments in the Era of Network Medicine
E. K. Silverman et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
Hypoxia-inducible factor (HIF)-1α suppression in myeloma cells blocks tumoral growth in vivo inhibiting angiogenesis and bone destruction
P. Storti et al.
LEUKEMIA (2013)
Passing Messages between Biological Networks to Refine Predicted Interactions
Kimberly Glass et al.
PLOS ONE (2013)
Overexpression of myeloid zinc finger 1 suppresses matrix metalloproteinase-2 expression and reduces invasiveness of SiHa human cervical cancer cells
Su-Ju Tsai et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Cancer Statistics, 2012
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
Combining Antiangiogenics to Overcome Resistance: Rationale and Clinical Experience
Victor Moreno Garcia et al.
CLINICAL CANCER RESEARCH (2012)
Combinatorial Assembly of Developmental Stage-Specific Enhancers Controls Gene Expression Programs during Human Erythropoiesis
Jian Xu et al.
DEVELOPMENTAL CELL (2012)
Targeting the Insulin Growth Factor Receptor 1
Fernanda I. Arnaldez et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2012)
Antiangiogenic Agents in Combination With Chemotherapy for the Treatment of Epithelial Ovarian Cancer
Deanna Teoh et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2012)
OCEANS: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Chemotherapy With or Without Bevacizumab in Patients With Platinum-Sensitive Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Carol Aghajanian et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Dynamic Change of Chromatin Conformation in Response to Hypoxia Enhances the Expression of GLUT3 (SLC2A3) by Cooperative Interaction of Hypoxia-Inducible Factor 1 and KDM3A
Imari Mimura et al.
MOLECULAR AND CELLULAR BIOLOGY (2012)
Extracts of Lycoris aurea Induce Apoptosis in Murine Sarcoma S180 Cells
Na Liao et al.
MOLECULES (2012)
The relevance and role of vascular endothelial growth factor C, matrix metalloproteinase-2 and E-cadherin in epithelial ovarian cancer
Ke-Jin Huang et al.
MEDICAL ONCOLOGY (2012)
Angiogenic mRNA and microRNA Gene Expression Signature Predicts a Novel Subtype of Serous Ovarian Cancer
Stefan Bentink et al.
PLOS ONE (2012)
A Natural Small Molecule Harmine Inhibits Angiogenesis and Suppresses Tumour Growth through Activation of p53 in Endothelial Cells
Fujun Dai et al.
PLOS ONE (2012)
Identification of Cys255 in HIF-1α as a novel site for development of covalent inhibitors of HIF-1α/ARNT PasB domain protein-protein interaction
Rosa Cardoso et al.
PROTEIN SCIENCE (2012)
Transcriptional and posttranslational inhibition of dioxin-mediated induction of CYP1A1 by harmine and harmol
Mohamed A. M. El Gendy et al.
TOXICOLOGY LETTERS (2012)
BRCA1 negatively regulates IGF-1 expression through an estrogen-responsive element-like site
H. J. Kang et al.
CELL DEATH & DISEASE (2012)
Serial measurements of serum PDGF-AA, PDGF-BB, FGF2, and VEGF in multiresistant ovarian cancer patients treated with bevacizumab
Christine Vestergaard Madsen et al.
JOURNAL OF OVARIAN RESEARCH (2012)
Molecular Predictors of Response to Antiangiogenesis Therapies
Armin Gerger et al.
CANCER JOURNAL (2011)
Epigenetic suppression of the TGF-beta pathway revealed by transcriptome profiling in ovarian cancer
Noriomi Matsumura et al.
GENOME RESEARCH (2011)
Overview of anti-angiogenic agents in development for ovarian cancer
Robert A. Burger
GYNECOLOGIC ONCOLOGY (2011)
The ARID Family Transcription Factor Bright Is Required for both Hematopoietic Stem Cell and B Lineage Development
Carol F. Webb et al.
MOLECULAR AND CELLULAR BIOLOGY (2011)
Integrated genomic analyses of ovarian carcinoma
D. Bell et al.
NATURE (2011)
Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
Robert A. Burger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Identification of residues in the N-terminal PAS domains important for dimerization of Arnt and AhR
Nan Hao et al.
NUCLEIC ACIDS RESEARCH (2011)
Dioxin exposure of human CD34+ hemopoietic cells induces gene expression modulation that recapitulates its in vivo clinical and biological effects
Nicola Stefano Fracchiolla et al.
TOXICOLOGY (2011)
Anti-angiogenic Agents in Ovarian Cancer: Dawn of a New Era?
Joyce Liu et al.
CURRENT ONCOLOGY REPORTS (2011)
Insulin-like Growth Factor-Dependent Proliferation and Survival of Triple-Negative Breast Cancer Cells: Implications for Therapy
Zoe Davison et al.
NEOPLASIA (2011)
Frozen robust multiarray analysis (fRMA)
Matthew N. McCall et al.
BIOSTATISTICS (2010)
NF-κB balances vascular regression and angiogenesis via chromatin remodeling and NFAT displacement
Aryn B. Aurora et al.
BLOOD (2010)
Biomarkers of angiogenesis and their role in the development of VEGF inhibitors
N. Murukesh et al.
BRITISH JOURNAL OF CANCER (2010)
An Atlas of Combinatorial Transcriptional Regulation in Mouse and Man
Timothy Ravasi et al.
CELL (2010)
Harman induces CYP1A1 enzyme through an aryl hydrocarbon receptor mechanism
Mohamed A. M. El Gendy et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2010)
The selective aryl hydrocarbon receptor modulator 6-methyl-1,3,8-trichlorodibenzofuran inhibits prostate tumor metastasis in TRAMP mice
Wayne A. Ftitz et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Dioxin-induced toxicity on vascular remodeling of the placenta
Ryuta Ishimura et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Gene regulatory network inference: Data integration in dynamic models-A review
Michael Hecker et al.
BIOSYSTEMS (2009)
BioMart - biological queries made easy
Damian Smedley et al.
BMC GENOMICS (2009)
Antiangiogenic drugs in ovarian cancer
G. C. Kumaran et al.
BRITISH JOURNAL OF CANCER (2009)
Dioxin Receptor Deficiency Impairs Angiogenesis by a Mechanism Involving VEGF-A Depletion in the Endothelium and Transforming Growth Factor-β Overexpression in the Stroma
Angel Carlos Roman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Inhibition of Furin/Proprotein Convertase-catalyzed Surface and Intracellular Processing by Small Molecules
Tomoko Komiyama et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Cediranib, an Oral Inhibitor of Vascular Endothelial Growth Factor Receptor Kinases, Is an Active Drug in Recurrent Epithelial Ovarian, Fallopian Tube, and Peritoneal Cancer
Ursula A. Matulonis et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Da Wei Huang et al.
NATURE PROTOCOLS (2009)
Biological Evaluation of Structurally Diverse Amaryllidaceae Alkaloids and their Synthetic Derivatives: Discovery of Novel Leads for Anticancer Drug Design
Antonio Evidente et al.
PLANTA MEDICA (2009)
Artificial ligand binding within the HIF2α PAS-B domain of the HIF2 transcription factor
Thomas H. Scheuermann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Divergent Transcriptomic Responses to Aryl Hydrocarbon Receptor Agonists between Rat and Human Primary Hepatocytes
Erik A. Carlson et al.
TOXICOLOGICAL SCIENCES (2009)
The cell biology of DNA methylation in mammals
Egor Prokhortchouk et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2008)
Gene set enrichment analysis using linear models and diagnostics
Assaf P. Oron et al.
BIOINFORMATICS (2008)
Spi-B inhibits human plasma cell differentiation by repressing BLIMP1 and XBP-1 expression
Heike Schmidlin et al.
BLOOD (2008)
The aryl hydrocarbon receptor (AhR) inhibits vanadate-induced vascular endothelial growth factor (VEGF) production in TRAMP prostates
Wayne A. Fritz et al.
CARCINOGENESIS (2008)
Gene expression profile and angiogenic marker correlates with response to neoadjuvant bevacizumab followed by bevacizumab plus chemotherapy in breast cancer
Sherry X. Yang et al.
CLINICAL CANCER RESEARCH (2008)
Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome
Richard W. Tothill et al.
CLINICAL CANCER RESEARCH (2008)
Activation of the VEGFR1 chromatin domain -: An angiogenic signal-ETS1/HIF-2α regulatory axis
Debasree Dutta et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Angiogenesis as a strategic target for ovarian cancer therapy
Whitney A. Spannuth et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2008)
Biomarkers of angiogenesis for the development of antiangiogenic therapies in oncology:: tools or decorations?
Cristiana Sessa et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2008)
Phase II trial of bevacizumab in persistent or recurrent epithelial ovarian cancer or primary peritoneal cancer: A Gynecologic oncology group study
Robert A. Burger et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Phase II study of bevacizumab in patients with platinum-resistant ovarian cancer or peritoneal serous cancer
Stephen A. Cannistra et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
The chronic fatigue syndrome: A comparative pathway analysis
Frank Emmert-Streib
JOURNAL OF COMPUTATIONAL BIOLOGY (2007)
The connectivity map: Using gene-expression signatures to connect small molecules, genes, and disease
Justin Lamb et al.
SCIENCE (2006)
BARX2 and estrogen receptor-α (ESR1) coordinatelyregulate the production of alternatively spliced ESR1 isoforms and control breast cancer cell growth and invasion
T. A. Stevens et al.
ONCOGENE (2006)
Genetic deletion of NAD(P)H:: Quinone oxidoreductase 1 abrogates activation of nuclear factor-κB, IκBα kinase, c-Jun N-terminal kinase, Akt, p38, and p44/42 mitogen-activated protein kinases and potentiates apoptosis
Kwang Seok Ahn et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Epigenetic therapy of cancer: past, present and future
CB Yoo et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Structural basis of ARNT PAS-B dimerization: Use of a common beta-sheet interface for hetero- and homodimerization
PB Card et al.
JOURNAL OF MOLECULAR BIOLOGY (2005)
Estimating gene regulatory networks and protein-protein interactions of Saccharomyces cerevisiae from multiple genome-wide data
N Nariai et al.
BIOINFORMATICS (2005)
Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data
MH Dai et al.
NUCLEIC ACIDS RESEARCH (2005)
Applied bioinformatics for the identification of regulatory elements
WW Wasserman et al.
NATURE REVIEWS GENETICS (2004)
Recruitment of thyroid hormone receptor/retinoblastoma-interacting protein 230 by the aryl hydrocarbon receptor nuclear translocator is required for the transcriptional response to both dioxin and hypoxia
TV Beischlag et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Cancer of the ovary
SA Cannistra
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Hierarchical thinking in network biology: the unbiased modularization of biochemical networks
JA Papin et al.
TRENDS IN BIOCHEMICAL SCIENCES (2004)
Antitussive activity of sigma-1 receptor agonists in the guinea-pig
C Brown et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Antitumor and antimetastatic effect of warfarin and heparins
V Bobek et al.
BIOMEDICINE & PHARMACOTHERAPY (2004)
Clinical implications of expression of ETS-1 in relation to angiogenesis in ovarian cancers
S Khatun et al.
CANCER SCIENCE (2003)
Exploration, normalization, and summaries of high density oligonucleotide array probe level data
RA Irizarry et al.
BIOSTATISTICS (2003)
Cooperative interaction of hypoxia-inducible factor-2α (HIF-2α) and Ets-1 in the transcriptional activation of vascular endothelial growth factor receptor-2 (Flk-1)
G Elvert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Direct interaction between BRCA1 and the estrogen receptor regulates vascular endothelial growth factor (VEGF) transcription and secretion in breast cancer cells
H Kawai et al.
ONCOGENE (2002)
Model-based clustering, discriminant analysis, and density estimation
C Fraley et al.
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION (2002)
Squalamine and cisplatin block angiogenesis and growth of human ovarian cancer cells with or without HER-2 gene overexpression
D Li et al.
ONCOGENE (2002)
Dominant-negative transcription factor AP-2 augments SB-2 melanoma tumor growth in vivo
JE Gershenwald et al.
ONCOGENE (2001)
The Ets family contains transcriptional activators and repressors involved in angiogenesis
E Lelièvre et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2001)
Molecular biology of the Ah receptor and its role in carcinogenesis
S Safe
TOXICOLOGY LETTERS (2001)
Role of ETS family transcription factors in vascular development and angiogenesis
Y Sato
CELL STRUCTURE AND FUNCTION (2001)
Role of the insulin-like growth factor family in cancer development and progression
H Yu et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
DNA binding sites: representation and discovery
GD Stormo
BIOINFORMATICS (2000)
Loss of function of the Prx1 and Prx2 homeobox genes alters architecture of the great elastic arteries and ductus arteriosus
M Bergwerff et al.
VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY (2000)
分享论文
